Finding the will and the way of ERAD substrate retrotranslocation

https://doi.org/10.1016/j.ceb.2012.05.010Get rights and content

ER-associated degradation (ERAD) is a mechanism by which numerous ER-localized proteins are targeted for cytosolic degradation by the ubiquitin–proteasome system. A surprising and still-cryptic requirement of this process is the energy dependent retrotranslocation of both lumenal and membrane-embedded ER proteins into the cytosol for ongoing ubiquitination and proteasomal destruction. The current understanding, results, and open questions are discussed below for this intriguing and critical process of ERAD.

Section snippets

ERAD and retrotranslocation

ER (endoplasmic reticulum)-associated protein degradation (ERAD) is a general term for the proteolytic pathways that degrade numerous ER proteins, including both luminal and integral membrane substrates [1, 2]. (We hesitate to use the term ‘clients’ for the substrates, since except for some members of Wall Street, most operations do not function to destroy their clients…). ERAD is primarily involved in protein quality control, since most ERAD substrates are damaged or misfolded proteins. ERAD

Retrotranslocation of all classes of ERAD substrates

Retrotranslocation was discovered in the Wolf group's pioneering studies of DER genes responsible for ER degradation of the prototype ERAD substrate CPY*. The normally vacuole-bound CPY* is retained and degraded in the ER by virtue of a point mutation that renders it unfoldable. The reasonable model that the entirely lumenal CPY* was degraded within the ER was shattered by the stunning discovery that DER2 encoded the cytoplasmic ubiquitin E2 known as Ubc7 [7••], indicating that lumenal CPY* was

Retrotranslocation employs the Cdc48/p97 AAA-ATPase

The ‘will’ or the energy requirements for retrotranslocation are unknown. However, current thinking is that removal of ER proteins might be expected to require cellular energy. For luminal substrates, if ER exit is analogous to ER entry, then complete unfolding of the substrate would be required, although this requirement is not clear. Experiments using strongly folded luminal domains such as DHFR appended to ERAD substrates to test the requirement for unfolding have provided diverse results [24

Way-ing in on egress: how do ERAD substrates leave the ER?

The old saying goes, “where there's a will, there's a way” and ERAD is no exception: if Cdc48/p97 provides the energetic ‘will’, then the way would be the actual route across and out of the ER membrane. This aspect of the ERAD remains unclear despite much activity from many groups. Because the usual way to get polypeptide into the ER is to employ a protein channel, it is reasonable to imagine that this is also the way proteins exit the ER. There have been a variety of candidates suggested and

Sec61 anterograde channel as an exit route

In the quest to find the ‘ERAD channel’, an early and reasonable suggestion was that the same channel used for ER entry, Sec61 and its partner subunits, was also employed for the similar task of moving polypeptides the other direction. Consistent with this idea, small peptides have been observed to exit the ER by this route [43], and mammalian Sec61α has been reported to associate with some ERAD substrates [44], proteasomes [45], and the HRD ERAD ligase complex [46, 47]. Unfortunately, because

Derlin: an alDERnative channel for retrotranslocation

A second channel candidate arose from proteomic studies of the viral US11 complex that orchestrates the extremely efficient degradation of single-spanning MHC-I molecules. They revealed a family of ER-localized candidate channel proteins known as derlins [53••, 54••], homologous to the very first ERAD gene ever identified, DER1, which is the yeast version of this family [55]. This connection between the mammalian and yeast studies implies a broadly conserved role for these factors in ERAD.

ERAD E3 ligases as channel components

A third class of pore candidates is suggested from ERAD E3 ligase topology. The two principal ERAD E3 ligases, Hrd1 and Doa10 both have large multispanning membrane domains (Hrd1: 6 spans, Doa10: 14 spans [56, 57]). Furthermore, the Hrd1 transmembrane domain has a high proportion of hydrophilic residues, as might be expected to line a peptide-transporting pore [58••]. These features have led to the appealing idea that in addition to ubiquitination, these E3s might provide a retrotranslocation

Towards an integrated picture of retrotranslocation

The collection of often ambiguous results described above may be providing clues about features of retrotranslocation, and resolution of those issues will be important steps in understanding the mechanism of this transport pathway. It may be that the lone still-undiscovered channel is a ‘small’ genetic target, and thus still awaiting discovery by assiduious genetic means. Another possibility for the lack of consensus on a channel is that we are dealing with the ‘Escape from New York’ scenario:

Lipid dynamics in retrotranslocation

Alternatively, it may be that there are no retrotranslocation channels, and that a totally novel route is employed to remove ERAD substrates to the cytosol. It has been suggested that the machinery that forms lipid droplets, which are derived from the ER outer leaflet and end up on the cytosol, might provide a non-channel mechanism for dislocation, at least for membrane proteins [67]. However, it is clear that at least in yeast the loss of lipid droplet formation by removal of the appropriate

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

  • • of special interest

  • •• of outstanding interest

Acknowledgements

We (RYH and TS) wish to thank members of our research groups past and present for discussions, data, and down-home fun. In addition, we dedicate this article to the memory of Steve Jobs, to whom nearly every biological scientist owes a debt of gratitude for powerful, friendly and whimsical computing tools of all stripe. RYH is supported by NIH grant DK051996, and by an ARRA supplement to that award. TS is generously supported by the Deutsche Forschungsgemeinschaft.

References (73)

  • B. DeLaBarre et al.

    Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains

    Nat Struct Biol

    (2003)
  • C. Taxis et al.

    Use of modular substrates demonstrates mechanistic diversity and reveals differences in chaperone requirement of ERAD

    J Biol Chem

    (2003)
  • S.L. Hrizo et al.

    The Hsp110 molecular chaperone stabilizes apolipoprotein B from endoplasmic reticulum-associated degradation (ERAD)

    J Biol Chem

    (2007)
  • E.J. Wiertz et al.

    Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction

    Nature

    (1996)
  • W. Ng et al.

    Characterization of the proteasome interaction with the Sec61 channel in the endoplasmic reticulum

    J Cell Sci

    (2007)
  • A. Schafer et al.

    Sec61p is part of the endoplasmic reticulum-associated degradation machinery

    EMBO J

    (2009)
  • R.K. Plemper et al.

    Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation

    Nature

    (1997)
  • M. Willer et al.

    Sec61p is required for ERAD-L: genetic dissection of the translocation and ERAD-L functions of Sec61P using novel derivatives of CPY

    J Biol Chem

    (2008)
  • P.M. Deak et al.

    Membrane topology and function of Der3/Hrd1p as a ubiquitin–protein ligase (E3) involved in endoplasmic reticulum degradation

    J Biol Chem

    (2001)
  • A.M. Stanley et al.

    Recognition of an ERAD-L substrate analyzed by site-specific in vivo photocrosslinking

    FEBS Lett

    (2011)
  • K.M. Bernardi et al.

    The E3 ubiquitin ligases Hrd1 and gp78 bind to and promote cholera toxin retro-translocation

    Mol Biol Cell

    (2010)
  • S. Li et al.

    Folding-competent and folding-defective forms of ricin A chain have different fates after retrotranslocation from the endoplasmic reticulum

    Mol Biol Cell

    (2010)
  • J.C. Christianson et al.

    Defining human ERAD networks through an integrative mapping strategy

    Nat Cell Biol

    (2011)
  • L. Fleig et al.

    Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins

    Mol Cell

    (2012)
  • M.H. Smith et al.

    Road to ruin: targeting proteins for degradation in the endoplasmic reticulum

    Science

    (2011)
  • M. Mehnert et al.

    ERAD ubiquitin ligases: multifunctional tools for protein quality control and waste disposal in the endoplasmic reticulum

    Bioessays

    (2010)
  • N.W. Bays et al.

    Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation

    Nat Cell Biol

    (2001)
  • R. Swanson et al.

    A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation

    Genes Dev

    (2001)
  • B. Chen et al.

    The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site

    Proc Natl Acad Sci USA

    (2006)
  • D.E. Grove et al.

    The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to facilitate RMA1 E3-dependent degradation of nascent CFTRDeltaF508

    Mol Biol Cell

    (2011)
  • M.M. Hiller et al.

    ER degradation of a misfolded luminal protein by the cytosolic ubiquitin–proteasome pathway

    Science

    (1996)
  • R.K. Plemper et al.

    Re-entering the translocon from the lumenal side of the endoplasmic reticulum. Studies on mutated carboxypeptidase yscY species

    FEBS Lett

    (1999)
  • J.L. Brodsky et al.

    The requirement for molecular chaperones during endoplasmic reticulum-associated protein degradation demonstrates that protein export and import are mechanistically distinct

    J Biol Chem

    (1999)
  • R. Mancini et al.

    Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events

    FASEB J

    (2000)
  • C.L. Ward et al.

    Degradation of CFTR by the ubiquitin–proteasome pathway

    Cell

    (1995)
  • R.Y. Hampton et al.

    Protein quality control as a strategy for cellular regulation: lessons from ubiquitin-mediated regulation of the sterol pathway

    Chem Rev

    (2009)
  • Cited by (114)

    • Endoplasmic Reticulum Stress in Disease

      2022, Encyclopedia of Cell Biology: Volume 1-6, Second Edition
    • Arabidopsis HIPP proteins regulate endoplasmic reticulum-associated degradation of CKX proteins and cytokinin responses

      2021, Molecular Plant
      Citation Excerpt :

      Given that the CKX1 domain mediating the interaction with HIPPs is localized in the luminal part of the protein (Figure 1 and Supplemental Figure 4C), BiFC between CKX1 and HIPP7 implicates that the CKX1 protein in the detected complex represents a form which was relocated to the cytosolic side of the membrane. This is consistent with the recent finding that CKX1 is targeted to the ERAD pathway (Niemann et al., 2015), which requires retrotranslocation of target proteins from the ER prior to delivery to the cytosolic/nuclear proteasome (Hampton and Sommer, 2012). To test whether CKX1–HIPP7 interaction involves the retrotranslocated CKX1 protein, we performed BiFC assays using CKX1421DLVK and CKX1409 that were unable to interact with HIPPs in yeast.

    View all citing articles on Scopus
    View full text